Nov 01, 2017 13:27 pm UTC| Business
NEWTON, Mass., Nov. 01, 2017 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that 14 abstracts have been selected for presentation, including three oral...
Student Transportation Inc. Charity Kicks Off Annual Holiday Donation Drive
Nov 01, 2017 13:27 pm UTC| Business
CHARLESTON, S.C., Nov. 01, 2017 -- Student Transportation Inc. (STI), a leader in school transportation, safety and fleet services, is teaming up with its charity, the STI Cares Foundation, to enhance the efforts of its...
Midwest CISSE Chapter Earns CyberPatriot Center of Excellence Designation
Nov 01, 2017 13:22 pm UTC| Business
ARLINGTON, Va., Nov. 01, 2017 -- The Air Force Association's (AFA) CyberPatriot Program Office has announced the Midwest CISSE Chapter (MCISSE) as its newest CyberPatriot Center of Excellence. ...
Fortress Biotech Announces Proposed Public Offering of Series A Preferred Stock
Nov 01, 2017 13:20 pm UTC| Business
NEW YORK, Nov. 01, 2017 -- Fortress Biotech, Inc. (Nasdaq:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Nov 01, 2017 13:19 pm UTC| Business
CAMBRIDGE, Mass., Nov. 01, 2017 -- Aileron Therapeutics (NASDAQ:ALRN), the clinical-stage leader in the field of stapled peptides developing therapeutics for cancers and other diseases, today announced that two...
Cascadian Therapeutics to Report Third Quarter 2017 Financial Results on November 8, 2017
Nov 01, 2017 13:19 pm UTC| Business
SEATTLE, Nov. 01, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that it will report its third quarter financial results after the close of the U.S....
Affimed to Present Clinical and Preclinical Data on Immune Cell Engagers at ASH
Nov 01, 2017 13:18 pm UTC| Business
Heidelberg, Germany, November 1, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that the Company...
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma